NIH-funded mobile clinic trial finds fewer deaths among people who inject drugs
NIH-funded mobile clinic trial finds fewer deaths among people who inject drugs
Updated at: November 5, 2026 at 01:18 AM
A clinical trial found fewer deaths among people who received integrated care through mobile medical units, the National Institutes of Health reported on November 4. The finding offers a promising lead for serving people who inject drugs, although researchers say it needs replication.
The HPTN 094 trial enrolled 409 adults without HIV who injected drugs and had opioid use disorder. None was taking medication for that disorder at enrolment. The study operated in five cities, including Houston, Los Angeles and New York.
Both groups received 26 weeks of help from peer navigators. One group also had access to HIV prevention, addiction treatment and limited additional care on mobile units. The comparison group was connected to existing community services.
By week 52, four participants in the mobile-unit group and 13 in the comparison group had died. The researchers estimated a 71 percent lower risk of death in the mobile-unit group. Mortality was a secondary outcome, and the death counts were small.
The intervention did not significantly improve its main outcomes: verified use of daily oral HIV prevention medicine and medication for opioid use disorder. This mixed result helps explain why the authors urge further research.
Unstable housing, stigma and fragmented services can make sustained care difficult. Researchers want to understand how accessible, integrated care might help, while also studying ways to improve acceptance and continued use of prevention medicines.
